Danish monkeypox vaccine maker widens deal with Canada

New study explains the link between diabetes and urinary tract infections
20 September 2022
Electronic health records may be key to improving patient care, study finds
20 September 2022

Danish monkeypox vaccine maker widens deal with Canada

Danish drugmaker Bavarian Nordic, the lone laboratory manufacturing a licensed vaccine against monkeypox, announced Tuesday a revised supply deal with Canada worth up to $470 million.

Comments are closed.